Daniel Eiras

1.8k citations

17 papers · 371 indexed · 1 hit paper · h-index 9

Impact in

Applied Microbiology and Biotechnology top 2%
- Antibiotic Use and Resistance
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Epidemiology 7
- Respiratory viral infections research 5
- Trypanosoma species research and implications 2
Pharmacology 4
- Antibiotics Pharmacokinetics and Efficacy 4

Co-authors: David P. Calfee (6 shared papers)E. Yoko Furuya (6 shared papers)Christine J. Kubin (3 shared papers)Brian Nelson (3 shared papers)Angela Loo (3 shared papers)Laura A. Kirkman (2 shared papers)Henry W. Murray (2 shared papers)Stephen G. Jenkins (2 shared papers)
Journals: Open Forum Infectious Diseases (6 papers)Antimicrobial Agents and Chemotherapy (3 papers)Infection Control and Hospital Epidemiology (2 papers)Clinical Infectious Diseases (1 paper)Chemical Research in Toxicology (1 paper)
Partner nations: United States United Kingdom Japan

In The Last Decade

Daniel Eiras

13 papers receiving 370 citations

Hit Papers

align trajectories log scale

Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons 2025 · 14 citations

Peers

Countries citing papers authored by Daniel Eiras

Since Specialization

Citations

This map shows the geographic impact of Daniel Eiras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Eiras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Eiras more than expected).

Fields of papers citing papers by Daniel Eiras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Eiras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Eiras. The network helps show where Daniel Eiras may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Eiras, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Eiras Line = papers co-authored together Daniel Eiras links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections Antimicrobial Agents and Chemotherapy ·Angela Gomez‐Simmonds, Brian Nelson, Daniel Eiras, Angela Loo, Stephen G. Jenkins, Susan Whittier, David P. Calfee, Michael J. Satlin, Christine J. Kubin, E. Yoko Furuya	2016	70
2	Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods Antimicrobial Agents and Chemotherapy ·Brian Nelson, Daniel Eiras, Angela Gomez‐Simmonds, Angela Loo, Michael J. Satlin, Stephen G. Jenkins, Susan Whittier, David P. Calfee, E. Yoko Furuya, Christine J. Kubin	2015	66
3	Role of IL-6 in an IL-10 and IL-4 Double Knockout Mouse Model Uniquely Susceptible to Acetaminophen-Induced Liver Injury Chemical Research in Toxicology ·Mohammed Bourdi, Daniel Eiras, Michael P. Holt, Marie R. Webster, Timothy P. Reilly, Kevin D. Welch, Lance R. Pohl	2007	64
4	Knowledge, Attitudes, and Practices Regarding Antimicrobial Use and Stewardship Among Prescribers at Acute-Care Hospitals Infection Control and Hospital Epidemiology ·Elizabeth Salsgiver, Daniel Bernstein, Matthew S. Simon, Daniel Eiras, William Greendyke, Christine J. Kubin, Monica Mehta, Brian Nelson, Angela Loo, Liz G. Ramos, Haomiao Jia, Lisa Saiman, E. Yoko Furuya, David P. Calfee	2018	49
5	Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers Current treatment options in infectious diseases ·Daniel Eiras, Laura A. Kirkman, Henry W. Murray	2015	44
6	Understanding Barriers to Optimal Cleaning and Disinfection in Hospitals: A Knowledge, Attitudes, and Practices Survey of Environmental Services Workers Infection Control and Hospital Epidemiology ·Daniel A. Bernstein, Elizabeth Salsgiver, Matthew S. Simon, William Greendyke, Daniel Eiras, Masahiro Ito, Dean Caruso, Timothy Woodward, Odette Perriel, Lisa Saiman, E. Yoko Furuya, David P. Calfee	2016	27
7	Nephrotoxicity Associated with Intravenous Polymyxin B Once- versus Twice-Daily Dosing Regimen Antimicrobial Agents and Chemotherapy ·Adeola Okoduwa, Nabeela Ahmed, Yi Guo, Marco R. Scipione, John Papadopoulos, Daniel Eiras, Yanina Dubrovskaya	2018	16
8	Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons Clinical Infectious Diseases ·Edward E. Walsh, Daniel Eiras, John Woodside, Qin Jiang, Michael A. Patton, Gonzalo Pérez Marc, Conrado J. Llapur, Mika Rämet, Yasushi Fukushima, Nazreen Hussen, José F. Cardona, Tarek Mikati, Agnieszka Zareba, Kumar Ilangovan, Maria Maddalena Lino, Elena Kalinina, Kena A. Swanson, Alejandra Gurtman, Iona Munjal Hit paper breakdown →	2025	14
9	Impact of Epstein–Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in Brazil Hematological Oncology ·Eni M. Souza, Otávio C.G. Baiocchi, Maria Aparecida Zanichelli, Antônio Corrêa Alves, Marianne G. Assis, Daniel Eiras, Cristine Dobo, José Salvador Rodrigues de Oliveira	2010	10
10	Case Report: Mucosal Leishmaniasis in New York City American Journal of Tropical Medicine and Hygiene ·Henry W. Murray, Daniel Eiras, Laura A. Kirkman, Raymond L. Chai, Daniel Caplivski	2020	5
11	Qualitative and Quantitative Assessment of Daily Cleaning of High-Touch Environmental Surfaces in Hospital Patient Rooms Open Forum Infectious Diseases ·Daniel Bernstein, Elizabeth Salsgiver, Matthew S. Simon, William Greendyke, Daniel Eiras, Masahiro Ito, Dean Caruso, Timothy Woodward, Odette Perriel, Lisa Saiman, E. Yoko Furuya, David P. Calfee	2015	3
12	Knowledge, Attitudes, and Practices of Environmental Service Workers Related to Environmental Cleaning and Healthcare-Associated Infections (HAI) Open Forum Infectious Diseases ·Daniel Bernstein, Elizabeth Salsgiver, Matthew S. Simon, William Greendyke, Daniel Eiras, Masahiro Ito, Dean Caruso, Timothy Woodward, Odette Perriel, Lisa Saiman, E. Yoko Furuya, David P. Calfee	2015	2
13	Nephrotoxicity associated with intravenous (IV) polymyxin B (PMB) once versus twice daily dosing Open Forum Infectious Diseases ·Nabeela Ahmed, Marco R. Scipione, John Papadopoulos, Daniel Eiras, Yanina Dubrovskaya	2016	1
14	1632. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High Neutralizing Titers in Older Adults Open Forum Infectious Diseases ·Yasushi Fukushima, José F. Cardona, Agnieszka Zareba, Qin Jiang, Daniel Eiras, Michael A. Patton, Kumar Ilangovan, Elliot DeHaan, Tarek Mikati, Elena Kalinina, David Cooper, Kenneth Koury, Annaliesa S. Anderson, Kena A. Swanson, William C. Gruber, Alejandra Gurtman, Beate Schmöele-Thoma	2023	0
15	RSVpreF Vaccine Elicits a Robust and Durable Immune Response Among Adults Aged 60 Years and Older Across an Entire RSV Season Daniel Eiras, Yasushi Fukushima, Jorge Cardona, Qin Jiang, Jayne V. Woodside, Tarek Mikati, M A Patton, Fumihiko Sakai, Elena Kalinina, David Cooper, Kenneth Koury, Ana C. Anderson, Iona Munjal, Kenneth D. Swanson, Alejandra Gurtman, Beate Schmöele-Thoma	2024	0
16	1630. Clinical Profile of Acute Respiratory Illness (ARI) Events in the Phase 3 Trial The RSV Vaccine Efficacy Study iN Older Adults Immunized against RSV Disease (RENOIR) Open Forum Infectious Diseases ·Gonzalo Pérez Marc, Edward E. Walsh, Elliot DeHaan, Conrado J. Llapur, Agnieszka Zareba, Qin Jiang, Kumar Ilangovan, John Woodside, Daniel Eiras, Tarek Mikati, Elena Kalinina, David Cooper, Annaliesa S. Anderson, Kena A. Swanson, William C. Gruber, Alejandra Gurtman, Beate Schmöele-Thoma	2023	0
17	P-605. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High and Durable Neutralizing Titers Across an Entire RSV Season among Older Adults Open Forum Infectious Diseases ·Jose F Cardona, Tarek Mikati, Yasushi Fukushima, Qin Jiang, Daniel Eiras, John Woodside, Michael Quinn Patton, Kumar Ilangovan, Elena Kalinina, David Cooper, Kena A. Swanson, Annaliesa S. Anderson, Alejandra Gurtman, Iona Munjal	2025	0

About Daniel Eiras

Daniel Eiras is a scholar working on Epidemiology, Pharmacology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Psychiatry and Mental health, having authored 17 papers that have together received 371 indexed citations. Recurring topics across this work include Respiratory viral infections research (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Infection Control and Ventilation (3 papers), Epilepsy research and treatment (3 papers), Trypanosoma species research and implications (2 papers), Animal Virus Infections Studies (2 papers), Research on Leishmaniasis Studies (2 papers) and Viral Infections and Immunology Research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (88 citations), Molecular Medicine (143 citations), Pharmacology (117 citations), Pharmacology (60 citations) and Clinical Biochemistry (33 citations). Daniel Eiras has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include David P. Calfee, E. Yoko Furuya, Christine J. Kubin, Brian Nelson, Angela Loo, Laura A. Kirkman, Henry W. Murray, Stephen G. Jenkins, Michael J. Satlin and Angela Gomez‐Simmonds. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases and Chemical Research in Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact